ALLAKOS INC.

(ALLK)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur ALLAKOS INC.
05/08ALLAKOS INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibi..
04/08ALLAKOS INC. Management's Discussion and Analysis of Financial Condition and Results o..
04/08Allakos Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June ..
04/08ALLAKOS : Provides Business Update and Reports Second Quarter 2022 Financial Results - For..
04/08Allakos Provides Business Update and Reports Second Quarter 2022 Financial Results
04/08Allakos Provides Business Update and Reports Second Quarter 2022 Financial Results
25/07ALLAKOS : Announces the Appointment of Dr. Amy Ladd to its Board of Directors - Form 8-K
25/07ALLAKOS INC. : Change in Directors or Principal Officers, Financial Statements and Exhibit..
25/07Allakos Announces the Appointment of Dr. Amy Ladd to its Board of Directors
25/07Allakos Inc. Announces the Appointment of Dr. Amy Ladd to Its Board of Directors
22/07Lonza-Aktien sinken nach Halbjahreszahlen
24/06ALLAKOS INC.(NASDAQGS : ALLK) dropped from Russell 2500 Index
24/06ALLAKOS INC.(NASDAQGS : ALLK) added to Russell Microcap Index
24/06ALLAKOS INC.(NASDAQGS : ALLK) dropped from Russell 2000 Growth Index
24/06ALLAKOS INC.(NASDAQGS : ALLK) added to Russell Microcap Value Index
24/06ALLAKOS INC.(NASDAQGS : ALLK) dropped from Russell 2000 Dynamic Index
24/06ALLAKOS INC.(NASDAQGS : ALLK) dropped from Russell 2000 Growth-Defensive Index
24/06ALLAKOS INC.(NASDAQGS : ALLK) dropped from Russell 2000 Defensive Index
24/06ALLAKOS INC.(NASDAQGS : ALLK) dropped from Russell 2000 Index
24/06ALLAKOS INC.(NASDAQGS : ALLK) dropped from Russell Small Cap Comp Growth Index
24/06ALLAKOS INC.(NASDAQGS : ALLK) dropped from Russell 3000 Growth Index
24/06ALLAKOS INC.(NASDAQGS : ALLK) dropped from Russell 3000E Growth Index
24/06ALLAKOS INC.(NASDAQGS : ALLK) dropped from Russell 3000 Index
24/06ALLAKOS INC.(NASDAQGS : ALLK) dropped from Russell Small Cap Completeness Index
24/06ALLAKOS INC.(NASDAQGS : ALLK) added to Russell 3000E Value Index
24/06ALLAKOS INC.(NASDAQGS : ALLK) dropped from Russell 2500 Growth Index
22/06ALLAKOS : Corporate Presentation
21/06ALLAKOS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
27/05ALLAKOS INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
20/05Allakos Files $250 Million Shelf
09/05Allakos Provides Business Update and Reports First Quarter 2022 Financial Results
09/05Allakos Files for Potential Offering of Up to $250 Million of Common Shares
06/05Allakos Q1 Loss Widens from Year Ago -- Stock Down Near 3% After-Hours
06/05ALLAKOS INC. Management's Discussion and Analysis of Financial Condition and Results o..
06/05Allakos Provides Business Update and Reports First Quarter 2022 Financial Results
06/05Allakos Provides Business Update and Reports First Quarter 2022 Financial Results
06/05Allakos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
20/04ALLAKOS INC. : Change in Directors or Principal Officers, Financial Statements and Exhibit..
20/04Allakos Inc. Announces Management Changes
05/04ALLAKOS INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial ..
21/03ALLAKOS INC.(NASDAQGS : ALLK) dropped from S&P Biotechnology Select Industry Index
02/03ALLAKOS INC. Management's Discussion and Analysis of Financial Condition and Results o..
01/03ALLAKOS : Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial..
01/03Allakos Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
01/03Allakos Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021
01/03Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financia..
01/03Allakos Inc. to Hold an End-Of-Phase 2 Meeting with the FDA During Second Quarter of 20..
28/02NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
16/02ALLAKOS INC. : Entry into a Material Definitive Agreement, Termination of a Material Defin..
15/02ALLAKOS INC. Other Events, Financial Statements and Exhibits (form 8-K/A)
15/02ALLAKOS : Investor Day Corporate Update
15/02TRANSCRIPT : Allakos Inc. - Analyst/Investor Day
15/02ALLAKOS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
01/02ALLAKOS : to Host Investor Day on February 15 - Form 8-K
01/02ALLAKOS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
01/02Allakos to Host Investor Day on February 15
2021Top Midday Gainers
2021Allakos Shares Climb After SMBC Nikko Upgrade
2021SOCIAL BUZZ : Wallstreetbets Stocks Mixed in Last Trading Day Before Christmas Break
2021NORTH AMERICAN MORNING BRIEFING : Stocks to Rise -2-
2021Paychex, Tesla rise; CalAmp, Allakos fall
2021ALLAKOS : Announces Topline Phase 3 Data from the ENIGMA 2 Study and Phase 2/3 Data from t..
2021ALLAKOS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
2021Health Care Stocks Retreat Pre-Bell Wednesday
2021Wall Street Set for Negative Open After Breaking Three-Day Losing Streak
2021Health Care
2021Top Premarket Decliners
2021Allakos' Lirentelimab Trials Fail to Meet Symptomatic Primary Endpoints -- Shares Drop ..
2021Allakos' Lirentelimab Trials Fail to Meet Symptomatic Primary Endpoints
2021Allakos Announces Topline Phase 3 Data from the ENIGMA 2 Study and Phase 2/3 Data from ..
2021Allakos Inc. Announces Topline Phase 3 Data from the ENIGMA 2 Study and Phase 2/3 Data ..
2021Allakos Expands Development of Lirentelimab Into Dermatitis, Hives, Asthma
2021ALLAKOS : Announces Expansion of Lirentelimab Development into Atopic Dermatitis, Chronic ..
2021ALLAKOS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
2021Allakos Announces Expansion of Lirentelimab Development into Atopic Dermatitis, Chronic..
1  2  3  4Suiv.
Prochain événement sur ALLAKOS INC.